IMMUNOCLOAK
Dead / Abandoned — Abandoned — no statement of use filed (as of 23 Dec 2024)
What this means for you
This application is over — abandoned 23 Dec 2024. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97822714
- Mark type
- Stylized text
- Filed
- 03 Mar 2023
- Published for opposition
- 26 Mar 2024
- Abandoned
- 23 Dec 2024
- Attorney of record
- Atul R. Singh
Goods and services
- Class 001 — Chemicals: Biochemical preparations for scientific purposes, namely, bioengineered compounds for polymerized membranes to support organ and tissue transplantation; Biochemical preparations for scientific purposes, namely, bioengineered compounds for polymerized membranes for use in organ and tissue transplantation; Biochemical preparations for scientific purposes, namely, bioengineered membranes to support organ and tissue transplantation; Biochemical preparations for scientific purposes, namely, bioengineered membranes for use in organ and tissue transplantation related applications; Biochemical preparations for scientific purposes, namely, bioengineered membranes for use in reducing and preventing allorecognition; Biochemical preparations for scientific purposes, namely, bioengineered membranes for use in reducing and preventing allorecognition in organ and tissue transplantation; Biochemical preparations for scientific purposes, namely, bioengineered membrane containing collagen, vitrogen, fibronectin and laminin; Biochemical preparations for scientific purposes, namely, bioengineered membrane that binds to the surface of blood vessels within the vasculature of an allograft; Biochemical preparations for scientific purposes, namely, bioengineered membrane that binds to the surface of blood vessels within the vasculature of an allograft to support organ and tissue transplantation
- Class 005 — Pharmaceuticals: Biochemical preparations for medical purposes, namely, bioengineered compounds for polymerized membranes to support organ and tissue transplantation; Biochemical preparations for medical purposes, namely, bioengineered compounds for polymerized membranes for use in organ and tissue transplantation; Biochemical preparations for medical purposes, namely, bioengineered membranes to support organ and tissue transplantation; Biochemical preparations for medical purposes, namely, bioengineered membranes for use in organ and tissue transplantation related applications; Biochemical preparations for medical purposes, namely, bioengineered membranes for use in reducing and preventing allorecognition; Biochemical preparations for medical purposes, namely, bioengineered membranes for use in reducing and preventing allorecognition in organ and tissue transplantation; Biochemical preparations for medical purposes, namely, bioengineered membrane containing collagen, vitrogen, fibronectin and laminin for organ and tissue transplantation, bioengineering tissue constructs to replace allografts and manufacturing immunomodified organs; Biochemical preparations for medical purposes, namely, bioengineered membrane that binds to the surface of blood vessels within the vasculature of an allograft; Biochemical preparations for medical purposes, namely, bioengineered membrane that binds to the surface of blood vessels within the vasculature of an allograft to support organ and tissue transplantation
Owner
- Breonics, Inc., Albany, NY, US
- Breonics, Inc., Albany, NY, US
Prosecution history
- 23 Dec 2024 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 23 Dec 2024 — ABANDONMENT - NO USE STATEMENT FILED
- 21 May 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 26 Mar 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 26 Mar 2024 — PUBLISHED FOR OPPOSITION
- 06 Mar 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 06 Mar 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 21 Feb 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 16 Feb 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 16 Feb 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 16 Feb 2024 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 16 Feb 2024 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 16 Feb 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 16 Feb 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 16 Feb 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED